Physician profile
Cassidy Dalton
NPI 1568001477
$2,706.47
in general payments reported to CMS, 2019-2025
15 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2023: $297 · 2024: $1,634 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578 · Travel and Lodging: $858 · Education: $13.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,578.13 |
| Travel and Lodging | $858.01 |
| Education | $13.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,315.54 | 2023-2024 | Interstim |
| Janssen Biotech, INC. | $283.46 | 2025 | Carvykti, Rybrevant |
| Sumitomo Pharma America, INC. | $268.12 | 2023-2025 | Gemtesa |
| Abbvie INC. | $261.24 | 2021-2025 | |
| Olympus America INC. | $162.61 | 2023-2024 | Gyrus Acmi, Itind System, Evis Exera III Video System Center |
| Astellas Pharma Global Development | $118.28 | 2024 | Xtandi |
| 180 Medical, INC. | $68.98 | 2024 | Cure Ultra Catheter |
| Astellas Pharma US INC | $46.68 | 2023-2024 | Myrbetriq |
| Alkermes, INC. | $39.33 | 2021 | |
| Neurocrine Biosciences, INC. | $28.68 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $27.16 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Janssen Pharmaceuticals, INC | $26.16 | 2021 | |
| Sunovion Pharmaceuticals INC. | $24.75 | 2021 | |
| Procept Biorobotics Corporation | $21.62 | 2025 | |
| Ferring Pharmaceuticals INC. | $13.86 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassidy Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.